Introduction
Diseases of the heart are a leading cause of morbidity and mortality
for both men and women worldwide, and impose significant economic burdens on
the healthcare systems. Despite substantial effort over the last several
decades, the molecular mechanisms underlying diseases of the heart remain
poorly understood.
Areas covered
Altered protein post-translational modifications (PTMs) and protein
isoform switching are increasingly recognized as important disease
mechanisms. Top-down high-resolution mass spectrometry (MS)-based proteomics
has emerged as the most powerful method for the comprehensive analysis of
PTMs and protein isoforms. Here, we will review recent technology
developments in the field of top-down proteomics, as well as highlight
recent studies utilizing top-down proteomics to decipher the cardiac
proteome for the understanding of the molecular mechanisms underlying
diseases of the heart.
Expert commentary
Top-down proteomics is a premier method for the global and
comprehensive study of protein isoforms and their PTMs, enabling the
identification of novel protein isoforms and PTMs, characterization of
sequence variations, and quantification of disease-associated alterations.
Despite significant challenges, continuous development of top-down
proteomics technology will greatly aid the dissection of the molecular
mechanisms underlying diseases of the hearts for the identification of novel
biomarkers and therapeutic targets.